The Role of Inflammatory Cytokines (Interleukins Family) in Human Disease
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Immunology".
Deadline for manuscript submissions: 31 July 2024 | Viewed by 1378
Special Issue Editor
Special Issue Information
Dear Colleagues,
In contemporary medical discourse, the profound influence of inflammatory cytokines, particularly those within the interleukin family, on human diseases has become a focal point of investigation. Interleukins, as integral signaling molecules in the immune system, intricately contribute to maintaining the delicate equilibrium between health and disease. The dysregulation of interleukin activity is implicated in a myriad of human disorders. While these cytokines play a pivotal role in orchestrating immune responses, their imbalanced levels or malfunction can instigate detrimental effects. Autoimmune diseases exemplify instances where the immune system’s misguided assault on the body’s own tissues is often linked to the overproduction or misbehavior of specific interleukins. Moreover, the intricate involvement of aberrant interleukin signaling in inflammatory bowel diseases and certain cancers underscores the far-reaching consequences of these molecular interactions. Comprehending the nuanced roles of interleukins in the initiation and progression of human diseases not only enhances our understanding but also opens avenues for targeted therapeutic interventions. As researchers delve deeper into the complexities of these molecular pathways, the prospect of developing precise treatments that modulate interleukin activity holds significant promise. This points towards a future where personalized medicine revolutionizes the healthcare landscape, offering tailored solutions for improved patient outcomes.
Dr. Diego Fresegna
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cytokine signaling
- immunotherapy
- immune modulation
- precision medicine
- disease pathogenesis
- immunological disorders
- therapeutic targets
- inflammation biomarkers
- immunomodulatory drugs
- cellular immune response
